Carvina Capital: Research‑Driven Equity Management

Carvina Capital is an independent investment firm focused on disciplined, evidence-based public equity strategies for investors worldwide, from individuals to institutions. This official brand profile highlights our approach, capabilities and recent press coverage.

Analysts review a rising candlestick chart—research-driven public-equity management at Carvina Capital.

About Carvina Capital

Founded in 2012 and based in Singapore, Carvina Capital practises a focused, research-first approach. Each idea is built from primary analysis, sensible valuation work and a clear risk framework. Capital is committed only when thesis, price and liquidity align with client objectives.

Governance, documentation and transparent reporting underpin our process. Clients receive clear, periodic updates and robust attribution, so outcomes are understood and decisions evaluated on their merits.

Evidence Over Market Noise

Decisions are anchored in research and documented reasoning. We prioritise durable facts over short‑term narrative shifts.

Valuation Discipline Matters

Price drives returns. We wait for warranted entry points and size positions to reflect upside, downside and liquidity.

Defined Risk, Sized Wisely

Risk limits are always set in advance with explicit sizing rules. Reviews enforce consistency across names and portfolios.

Aligned To Client Goals

Objectives are agreed upfront and revisited. Reporting is clear, timely and built to support informed dialogue.

Capabilities at a Glance

Public Equities

Long‑only, research‑led portfolios with active risk controls and capacity awareness.

Client Reporting

Structured, timely reporting with clear attribution and measured commentary.

Our Latest Press Highlights

BusinessInsider.com Logo

Carvina Capital on EU’s 1.16B AI Push

Our commentary frames the EU’s programme as a move from pilots to production‑scale AI, where execution quality and compliance clarity will separate leaders from laggards.

Yahoo! Finance Logo

Medline IPO: Supply‑Chain Meets Valuation

We discuss how operating fundamentals, pricing dynamics and investor appetite could shape outcomes around a potential Medline listing.

Reuters Logo

China’s Tech Drive and U.S. Leadership

Our analysis explores China’s accelerating AI and semiconductor ecosystem and the implications for global technology competition.

Contact Us

For onboarding and detailed materials, please visit the main website.

Leave a Message

Continue to the Main Site

Strategy detail, perspectives and client materials are available on carvina.com.